Dysregulated growth hormone–insulin-like growth factor-1 axis in adults with metabolic dysfunction-associated steatotic liver disease: a meta-analysis
Nutrition, Metabolism and Cardiovascular Diseases · 2026-12 · 36 (12) · 104853
DOI: 10.1016/j.numecd.2026.104853 ↗Kurz gefasst
Metaanalyse in der Zeitschrift Nutrition, Metabolism and Cardiovascular Diseases, 2026-12. Verfasst von Dario Messetti und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of Verona, Verona, Italy; Metabolic Diseases Research Unit, IRCCS Sacro Cuore - Don Calabria Hospital, Negrar di V…. Hauptthemen laut MEDLINE: Insulin-Like Growth Factor I, Human Growth Hormone, Fatty Liver, Non-alcoholic Fatty Liver Disease. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: Università degli Studi di Verona.
Abstract (Originalsprache)
AIM: A dysregulated growth hormone (GH)-insulin-like growth factor-1 (IGF-1) axis may contribute to the development and progression of metabolic dysfunction-associated steatotic liver disease (MASLD). However, the available evidence remains inconsistent. DATA SYNTHESIS: We systematically searched PubMed and Scopus from database inception through 31 January 2026 to identify eligible observational studies assessing the association between circulating GH and IGF-1 levels and MASLD (diagnosed by liver biopsy or imaging). The primary outcome was the difference in circulating GH and IGF-1 levels between adults (age >18 years) with and without MASLD. Effect sizes were expressed as weighted mean differences (WMDs) with 95% confidence intervals (95%CI). A total of 18 observational studies were included. Fourteen studies (13,112 participants) measured circulating IGF-1 levels, five studies (7500 participants) measured circulating GH levels, and one study assessed both hormones. Individuals with MASLD had significantly lower circulating GH (random-effects WMD: -0.34 ng/ml; 95%CI, -0.61 to -0.07; I2 = 81.5%) and IGF-1 (random-effects WMD: -24.85 ng/ml; 95%CI, -37.88 to -11.81; I2 = 94.8%) levels than controls. Circulating IGF-1 levels were also lower in individuals with biopsy-confirmed metabolic dysfunction-associated steatohepatitis or advanced liver fibrosis (F2-F4 stages). Sensitivity analyses did not substantially alter these findings. CONCLUSION: Circulating GH and IGF-1 levels are inversely associated with the presence and severity of MASLD. Further studies are needed to better understand the complex but existing link between a dysregulated (suppressed) GH-IGF-1 axis and MASLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, University of Verona, Verona, Italy; Metabolic Diseases Research Unit, IRCCS Sacro Cuore - Don Calabria Hospital, Negrar di Valpolicella, Italy.
- Department of Medicine, University of Verona, Verona, Italy; Metabolic Diseases Research Unit, IRCCS Sacro Cuore - Don Calabria Hospital, Negrar di Valpolicella, Italy. Electronic address: alessandro.mantovani@univr.it.
- Laboratory of Pharmacology, School of Medicine, Aristotle University of Thessaloniki, Thessaloniki, Greece.
Förderung
- Università degli Studi di Verona
Zitieren
APA
Messetti, D., Mantovani, A., Morandin, R., Rolli, N., Molinaroli, E., Giachetti, G., Zoco, M., Polyzos, S. A., & Targher, G. (2026). Dysregulated growth hormone–insulin-like growth factor-1 axis in adults with metabolic dysfunction-associated steatotic liver disease: a meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases, 36(12), 104853. https://doi.org/10.1016/j.numecd.2026.104853
Vancouver
Messetti D, Mantovani A, Morandin R, Rolli N, Molinaroli E, Giachetti G, et al. Dysregulated growth hormone–insulin-like growth factor-1 axis in adults with metabolic dysfunction-associated steatotic liver disease: a meta-analysis. Nutrition, Metabolism and Cardiovascular Diseases. 2026;36(12):104853. doi:10.1016/j.numecd.2026.104853
BibTeX
@article{Messetti2026,
author = {Messetti, Dario and Mantovani, Alessandro and Morandin, Riccardo and Rolli, Nicoletta and Molinaroli, Elisa and Giachetti, Gabriele and Zoco, Marta and Polyzos, Stergios A and Targher, Giovanni},
title = {Dysregulated growth hormone–insulin-like growth factor-1 axis in adults with metabolic dysfunction-associated steatotic liver disease: a meta-analysis},
journal = {Nutrition, Metabolism and Cardiovascular Diseases},
year = {2026},
volume = {36},
number = {12},
pages = {104853},
doi = {10.1016/j.numecd.2026.104853}
}
EUVIMED